BLISS GVS PHARMA
Back to Balance Sheet
|
BLISS GVS PHARMA Last 5 Year Total Debt History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Debt | ₹2.93 Cr | ₹71 Cr | ₹88 Cr | ₹98 Cr | ₹105 Cr |
What is the latest Total Debt ratio of BLISS GVS PHARMA ?
| Year | Total Debt |
|---|---|
| Mar2026 | ₹2.93 Cr |
| Mar2025 | ₹71 Cr |
| Mar2024 | ₹88 Cr |
| Mar2023 | ₹98 Cr |
| Mar2022 | ₹105 Cr |
How is Total Debt of BLISS GVS PHARMA Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2026 | ₹2.93 Cr | -95.88 | |
| Mar2025 | ₹71 Cr | -19.17 | |
| Mar2024 | ₹88 Cr | -10.46 | |
| Mar2023 | ₹98 Cr | -6.56 | |
| Mar2022 | ₹105 Cr | - | |
Compare Total Debt of peers of BLISS GVS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BLISS GVS PHARMA | ₹7,840.7 Cr | 6.8% | 31.9% | 368.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,478.0 Cr | -0.2% | -3.2% | 12.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,031.0 Cr | 2% | 5.3% | 57.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,216.0 Cr | -2.4% | -3.1% | 36.4% | Stock Analytics | |
| CIPLA | ₹112,205.0 Cr | 0.6% | -2.2% | -9.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,040.0 Cr | 0.9% | 4% | -7.6% | Stock Analytics | |
BLISS GVS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BLISS GVS PHARMA | 6.8% |
31.9% |
368.5% |
| SENSEX | -2.8% |
-6.1% |
-11.9% |
You may also like the below Video Courses